Drugs / Hylase
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT03394131 | Jul 2017 → May 2018 | carpal tunnel syndrome | Assiut University | Unknown | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 0 | NCT05370963 Comparator | May 2022 → May 2023 | chronic pain syndrome | Minia University | Completed | No outcome recorded |
| Phase 0 | NCT05349448 Comparator | Mar → Nov 2022 | neuropathy, painful | Minia University | Unknown | No outcome recorded |
| — | NCT03177915 Comparator | Mar → Dec 2016 | carpal tunnel syndrome, chronic pain syndrome | Assiut University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hylase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05370963 ↗ |
| Known as | hyalase | “hyalase and dexmedtemodine are well known adjuvants given epidurally to alleviate chronic back pain.” NCT05370963 ↗ |
| Route | Other | “given epidurally” NCT05370963 ↗ |